- Home
- GBIO vs GENK Comparison
GBIO vs GENK Comparison
Compare GBIO & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- GENK
- Stock Information
- Founded
- GBIO 2016
- GENK 2011
- Country
- GBIO United States
- GENK United States
- Employees
- GBIO 115
- GENK N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- GBIO Health Care
- GENK Consumer Discretionary
- Exchange
- GBIO Nasdaq
- GENK Nasdaq
- Market Cap
- GBIO 29.2M
- GENK 23.6M
- IPO Year
- GBIO 2020
- GENK 2023
- Fundamental
- Price
- GBIO $0.36
- GENK $4.70
- Analyst Decision
- GBIO Strong Buy
- GENK Strong Buy
- Analyst Count
- GBIO 4
- GENK 3
- Target Price
- GBIO $7.33
- GENK $12.17
- AVG Volume (30 Days)
- GBIO 493.7K
- GENK 35.6K
- Earning Date
- GBIO 05-07-2025
- GENK 05-13-2025
- Dividend Yield
- GBIO N/A
- GENK N/A
- EPS Growth
- GBIO N/A
- GENK 62.05
- EPS
- GBIO N/A
- GENK 0.13
- Revenue
- GBIO $24,556,000.00
- GENK $208,380,000.00
- Revenue This Year
- GBIO N/A
- GENK $20.48
- Revenue Next Year
- GBIO $10.90
- GENK $21.64
- P/E Ratio
- GBIO N/A
- GENK $35.56
- Revenue Growth
- GBIO 146.47
- GENK 15.12
- 52 Week Low
- GBIO $0.32
- GENK $3.99
- 52 Week High
- GBIO $4.34
- GENK $13.12
- Technical
- Relative Strength Index (RSI)
- GBIO 39.03
- GENK 52.17
- Support Level
- GBIO $0.36
- GENK $4.30
- Resistance Level
- GBIO $0.41
- GENK $4.63
- Average True Range (ATR)
- GBIO 0.04
- GENK 0.25
- MACD
- GBIO -0.00
- GENK 0.08
- Stochastic Oscillator
- GBIO 9.09
- GENK 69.77
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.